Venture Creation Firm Reveals Strategies for Launching New Companies & Forming Collaborations

In this exclusive Pharm Exec Podcast episode with Paul Biondi, executive partner at Flagship Pioneering (the venture creation firm behind Moderna and many other life science firms) and president of Pioneering Medicines, Meg Rivers, managing editor, asks Biondi about:

• The process of founding a company
• What factors they consider when deciding whether to partner with a pharmaceutical company (like their partnership with Novo Nordisk) or a foundation (like their partnership with the Cystic Fibrosis Foundation)—along with what makes one organization stand out from another
• Where science is booming in pharma right now
• Deciding whether to found a company looking to launch innovations in an existing space vs. pursue innovations in an untapped space
• Signs that a company will achieve commercial success from early on

About the speaker

Paul Biondi is an executive partner at Flagship Pioneering and president of Pioneering Medicines. In his role at Flagship, Biondi works with growth company CEOs and their teams to achieve the best attainable value for each company and serves on the boards of selected Flagship companies, including Seres Therapeutics and Valo Health. Biondi joined Flagship following many years at Bristol-Myers Squibb where he held senior leadership roles in both business development and research and development.

About the Pharm Exec Podcast

The editors of Pharmaceutical Executivebring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.

Listen to this podcast on SoundCloud, Spotify, Google Podcasts, or Apple Podcasts.